Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)
NCT02246270
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Urinary Tract Infections
Interventions
DRUG:
Intravesical Heparin
OTHER:
Placebo
Sponsor
University of Oklahoma